Beyond depression: Evaluation of newer indications and off-label uses for SSRIs

Formulary

Volumn 37, Issue 6, 2002, Pages 312-319

  Lee, Kelly C ^a   Feldman, Mitchell D ^a   Finley, Patrick R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALCOHOLISM; ANOREXIA NERVOSA; BINGE EATING DISORDER; BULIMIA; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG CAPSULE; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; EATING DISORDER; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; MALE SEXUAL DYSFUNCTION; PAIN; PREMATURE EJACULATION; PREMENSTRUAL DYSPHORIC DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEXUAL DYSFUNCTION; TABLET;

EID: 0036281947     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Pharmacologic approaches to the management of alcoholism
2. The use of selective serotonin re-uptake inhibitors in treating alcoholic subtypes
3. Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies
4. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
5. Effect of fluoxetine on alcohol consumption in male alcoholics
6. Flu-oxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
7. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
8. Double-blind clinical trial of sertraline treatment for alcohol dependence
9. A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: Adjunctive pharmacotherapy during and after inpatient treatment
10. The serotonin uptake inhibitor citalopram attenuates ethanol intake
11. Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems
12. Types of alcoholics: Concurrent and predictive validity of some common classification schemes
13. Flu-oxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics
14. Sertraline treatment for alcohol dependence: Interactive effects of medication and alcoholic sub-type
15. The efficacy of newer antidepressants in the treatment of chronic pain: A review of current literature
16. Fluoxetine prophylaxis of migraine
17. Double-blind trial of fluoxetine: Chronic daily headache and migraine
18. Fluoxetine for migraine prophylaxis: A double-blind trial
19. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache
20. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis
21. Chronic tension-type headache, mood depression and serotonin: Therapeutic effects of fluvoxamine and mianserine
22. In the treatment of chronic tension-type headache. An explanatory double-blind trial
23. The use of fluoxetine in the treatment of headache
24. Paroxetine in the treatment of chronic daily headache
25. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
26. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
27. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: A patient-blinded dose-escalation study
28. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
29. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia
30. A randomized controlled trial of citalopram in the treatment of fibromyalgia
31. A randomized trial of fluoxetine versus amitriptyline in musculo-skeletal pain
32. An evaluation of antidepressants in rheumatic pain conditions
33. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity
34. Fluoxetine versus sertraline and paroxetine in major depressive disorder: Changes in weight with long-term treatment
35. The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa
36. Long-term fluoxetine treatment of bulimia nervosa
37. Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial
38. Fluvoxamine in prevention of relapse in bulimia nervosa: Effects on eating-specific psychopathology
39. An open trial of fluoxetine in patients with anorexia nervosa
40. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa
41. Placebo-controlled trial of sertraline in the treatment of binge eating disorder
42. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters
43. Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices
44. Premenstrual dysphoria and the serotonin system: Pathophysiology and treatment
45. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
46. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
47. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
48. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study
49. Fluoxetine in the treatment of premenstrual dysphoria
50. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression
51. Sexual side effects of antidepressant drugs
52. Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study
53. The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo controlled study
54. Sertraline treatment for premature ejaculation
55. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline
56. Sertraline hydrochloride forpremature ejaculation